Outcomes of children with BCR-ABL1-like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease
dc.contributor.author | Roberts, K. | |
dc.contributor.author | Pei, D. | |
dc.contributor.author | Campana, D. | |
dc.contributor.author | Payne-Turner, D. | |
dc.contributor.author | Li, Y. | |
dc.contributor.author | Cheng, C. | |
dc.contributor.author | Sandlund, J. | |
dc.contributor.author | Jeha, S. | |
dc.contributor.author | Easton, J. | |
dc.contributor.author | Becksfort, J. | |
dc.contributor.author | Zhang, J. | |
dc.contributor.author | Coustan-Smith, E. | |
dc.contributor.author | Raimondi, S. | |
dc.contributor.author | Leung, W. | |
dc.contributor.author | Relling, M. | |
dc.contributor.author | Evans, W. | |
dc.contributor.author | Downing, J. | |
dc.contributor.author | Mullighan, C. | |
dc.contributor.author | Pui, C. | |
dc.date.issued | 2014 | |
dc.description.abstract | Abstract not available | |
dc.description.statementofresponsibility | Kathryn G. Roberts, Deqing Pei, Dario Campana, Debbie Payne-Turner, Yongjin Li, Cheng Cheng, John T. Sandlund, Sima Jeha, John Easton, Jared Becksfort, Jinghui Zhang, Elaine Coustan-Smith, Susana C. Raimondi, Wing H. Leung, Mary V. Relling, William E. Evans, James R. Downing, Charles G. Mullighan, and Ching-Hon Pui | |
dc.identifier.citation | Journal of Clinical Oncology, 2014; 32(27):3012-3020 | |
dc.identifier.doi | 10.1200/JCO.2014.55.4105 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.issn | 1527-7755 | |
dc.identifier.orcid | Mullighan, C. [0000-0002-1871-1850] | |
dc.identifier.uri | http://hdl.handle.net/2440/103707 | |
dc.language.iso | en | |
dc.publisher | American Society of Clinical Oncology | |
dc.relation.grant | NHMRC | |
dc.rights | © 2014 by American Society of Clinical Oncology | |
dc.source.uri | https://doi.org/10.1200/jco.2014.55.4105 | |
dc.subject | Gene expression profiling; Kaplan-Meier estimate; molecular targeted therapy; percusor cell lymphoblastic leukemia-lymphoma | |
dc.title | Outcomes of children with BCR-ABL1-like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease | |
dc.type | Journal article | |
pubs.publication-status | Published |